pocketful logo
IOL Chemicals & Pharmaceuticals Ltd logo

IOL Chemicals & Pharmaceuticals Ltd

NSE: IOLCP BSE: 524164

71.62

(-1.32%)

Thu, 12 Mar 2026, 00:09 am

IOL Chemicals & Pharmaceuticals Analysis

dividend

thumbs up icon

Pros

  • Dividends paid are thoroughly covered by earnings (21.2x coverage).
  • IOL Chemicals and Pharmaceuticals's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
thumbs up icon

Cons

  • IOL Chemicals and Pharmaceuticals only just started paying a dividend, it is too early to tell if payments are increasing.
  • It is too early to tell whether IOL Chemicals and Pharmaceuticals has stable dividend payments.
  • IOL Chemicals and Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).

health

thumbs up icon

Pros

  • IOL Chemicals and Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • IOL Chemicals and Pharmaceuticals is profitable, therefore cash runway is not a concern.
  • IOL Chemicals and Pharmaceuticals is profitable, therefore cash runway is not a concern.
  • Debt is well covered by operating cash flow (842.4%, greater than 20% of total debt).
  • Debt is covered by short term assets, assets are 12x debt.
  • IOL Chemicals and Pharmaceuticals's cash and other short term assets cover its long term commitments.
  • The level of debt compared to net worth has been reduced over the past 5 years (193.2% vs 6.9% today).
  • Interest payments on debt are well covered by earnings (EBIT is 25.7x coverage).
  • IOL Chemicals and Pharmaceuticals's level of debt (6.9%) compared to net worth is satisfactory (less than 40%).
thumbs up icon

Cons

  • High level of physical assets or inventory.

management

thumbs up icon

Pros

  • The tenure for the IOL Chemicals and Pharmaceuticals board of directors is about average.
  • Varinder's compensation has been consistent with company performance over the past year, both up more than 20%.
  • The average tenure for the IOL Chemicals and Pharmaceuticals management team is over 5 years, this suggests they are a seasoned and experienced team.
thumbs up icon

Cons

  • Varinder's remuneration is higher than average for companies of similar size in India.

misc

thumbs up icon

Pros

    thumbs up icon

    Cons

    • IOL Chemicals and Pharmaceuticals is not covered by any analysts.
    • IOL Chemicals and Pharmaceuticals has significant price volatility in the past 3 months.

    past

    thumbs up icon

    Pros

    • IOL Chemicals and Pharmaceuticals has delivered over 20% year on year earnings growth in the past 5 years.
    • IOL Chemicals and Pharmaceuticals used its assets more efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
    • IOL Chemicals and Pharmaceuticals has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
    • IOL Chemicals and Pharmaceuticals made outstanding use of shareholders’ funds last year (Return on Equity greater than 40%).
    • IOL Chemicals and Pharmaceuticals's earnings growth has exceeded the IN Pharmaceuticals industry average in the past year (52.1% vs 22.7%).
    thumbs up icon

    Cons

    • IOL Chemicals and Pharmaceuticals's 1-year earnings growth is less than its 5-year average (52.1% vs 81.9%)

    value

    thumbs up icon

    Pros

    • IOL Chemicals and Pharmaceuticals's share price is below the future cash flow value, and at a moderate discount (> 20%).
    • IOL Chemicals and Pharmaceuticals's share price is below the future cash flow value, and at a substantial discount (> 40%).
    • IOL Chemicals and Pharmaceuticals is good value based on earnings compared to the IN Pharmaceuticals industry average.
    • IOL Chemicals and Pharmaceuticals is good value based on earnings compared to the India market.
    • 524164 outperformed the Pharmaceuticals industry which returned 26.7% over the past year.
    • 524164 outperformed the Market in India which returned -14.5% over the past year.
    thumbs up icon

    Cons

    • IOL Chemicals and Pharmaceuticals is overvalued based on assets compared to the IN Pharmaceuticals industry average.
    • BSE:524164 is down -7.9% underperforming the Pharmaceuticals industry which returned 6.8% over the past month.
    • BSE:524164 is down -7.9% underperforming the market in India which returned 8% over the past month.

    Open Your Free Demat Account Now!

    Step into a world of zero fees and limitless opportunities!

    pocketful logo

    2022-25 Pocketful. All rights reserved, Built with in India

    Version -5.76

    app image 1app image 2

    Explore

    Calculatorsfooter arrow down icon
    Popular Calculatorsfooter arrow down icon
    Group Stocksfooter arrow down icon

    Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800